Semaglutide is a medication belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist family of meds
For those considering more intensive medical interventions, weight loss surgery is another option, though it costs significantly more at $3,000 to $35,000 depending on the procedure and insurance coverage
Common side effects, especially early in treatment, can include nausea (which often diminishes as the body adjusts), vomiting, diarrhea or constipation, decreased appetite, and injection site reactions
What sterile compounding standard does the post say 503A pharmacies must meet
Zepbound (GLP-1/GIP) Mechanism : Dual agonist that stimulates both GIP and GLP-1 receptors
Zepbound is chemically identical to Mounjaro, containing the same active ingredient at the same strength, but it is marketed under a different name when used for weight-loss treatment